Vliyanie Rimonabanta na metabolicheskie faktory riskaserdechno-sosudistykh zabolevaniy u patsientovs izbytochnym vesom i dislipidemiey
https://doi.org/10.14341/2071-8713-4944
References
1. Effects of Rimonabant on metabolic risk factors in overweight patients with dyslipidemia. Despres JP, Golay A, Sjostrom L. NEJM, 2005.
Review
For citations:
Vliyanie Rimonabanta na metabolicheskie faktory riskaserdechno-sosudistykh zabolevaniy u patsientovs izbytochnym vesom i dislipidemiey. Obesity and metabolism. 2006;3(1):52-52. (In Russ.) https://doi.org/10.14341/2071-8713-4944
Views:
342
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
